Journals / Mucosa / 2018 / Cilt: 1 - Sayı: 1

FOXP3+ Treg cells and interleukin-23 expression in the intestinal mucosa of children with ulcerative colitis

Ülseratif kolitli çocukların intestinal mukozasında FOXP3+ Treg hücreleri ve interlökin-23 ekspresyonu

Journal
Mucosa
Pages
10–17
Publication Date
2018-06-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These data indicate that new therapeutic options directed toward inhibiting the IL23 pathway and raising Treg cell numbers may permit more efficacious treatment of UC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/AimsUlcerative colitis (UC) is thought to result from an aberrant immune response.
📊
Key Findings & Data:Forkhead box P3 (FOXP3) regulatory T (Treg) cells and Interleukin (IL)-23/T-helper 17 pathway play an important role in the pathogenesis of inflammatory bowel disease, but little is known about their role in children with UC.
💡
Conclusion & Impact:These data indicate that new therapeutic options directed toward inhibiting the IL23 pathway and raising Treg cell numbers may permit more efficacious treatment of UC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ülseratif kolit · Çocuk · İnterlökin-23

Abstract

Background/AimsUlcerative colitis (UC) is thought to result from an aberrant immune response. Forkhead box P3 (FOXP3) regulatory T (Treg) cells and Interleukin (IL)-23/T-helper 17 pathway play an important role in the pathogenesis of inflammatory bowel disease, but little is known about their role in children with UC. The aim of this study was to investigate the role of FOXP3 and IL-23 in the pathogenesis of UC by determining them in intestinal tissues of children with the disease.Materials and MethodsWe studied 29 patients with UC (18 pancolitis, nine left-sided colitis, and two proctocolitis) and 11 control subjects. Immunohistochemistry was used to examine FOXP3+ Treg cells and IL-23 in intestinal biopsy specimens from UC patients and from non-inflamed tissues in the control group.ResultsUC patients’ FOXP3+ Treg cells were significantly higher than those of the control group (45.67% ± 10.83 vs. 22.06% ± 8.09, p=0.007). IL-23 expression in patients with UC were significantly higher than those of the control subjects (24.33% ± 13.81 vs. 12.91% ± 5.06, p=0.009). FOXP3+ Treg cells (43.21% ± 16.97) and IL-23 (25.12% ± 14.98) expression in patients with pancolitis were higher than in the control group (p=0.012 vs p=0.022). However, no differences were determined in FOXP3+ Treg cells and IL-23 in patients with left colon involvement and proctocolitis compared to the control group. Conclusions FOXP3+ Treg cell and IL-23 expression were higher in the intestinal mucosa of children with UC. These data indicate that new therapeutic options directed toward inhibiting the IL23 pathway and raising Treg cell numbers may permit more efficacious treatment of UC.

Özet

AmaçÜlseratif kolitin (UK), anormal immün yanıt sonucu geliştiği düşünülmektedir. Forkhead box P3 (FOXP3) T regülatuvar (Treg) hücreleri ve interlökin (IL)-23/T-helper 17 yolağı, inflamatuvar bağırsak hastalığının patogenezinde önemli bir rol oynamaktadır. Ancak bu yolağın UK'li çocuklardaki rolü ile ilgili bilgilerimiz sınırlıdır. Bu çalışmanın amacı UK’li çocukların bağırsak mukozasında FOXP3 ve IL-23’ün düzeylerinin belirlenerek, hastalığın patogenezindeki rollerinin araştırılmasıdır.Gereç ve yöntemlerYirmi dokuz UK’li hasta (18 pankolit, dokuz sol kolon tutulumlu ve iki proktokolit) ve 11 kontrol hastası çalışmaya dahil edildi. İmmünohistokimyasal boyama yöntemi ile, UK hastaların inflamasyonlu dokularından ve kontrol hastalarının inflamasyon içermeyen dokularından alınan biyopsi örneklerinde FOXP3+ Treg hücreleri ve IL-23 düzeyleri incelendi.BulgularÜlseratif kolitli hastalarda FOXP3+ Treg hücre seviyesi kontrol grubuna göre önemli oranda yüksekti (%45.67 ± 10.83 ve %22.06 ± 8.09, p=0.007). IL-23 düzeyi de UK hastalarında kontrol grubuna göre anlamlı olarak yüksekti (24.33% ± 13.81 vs. 12.91% ± 5.06, p=0.009). Pankolitli hastalarda FOXP3+ Treg hücreleri (%43.21 ± 16.97) ve IL-23 (%25.12 ± 14.98) ekspresyonu kontrol grubundan daha yüksek olduğu görüldü (p=0.012 ve p=0.022). Ancak, kontrol grubu ile sol kolon tutulumu ve proktokoliti olan hastalar arasında FOXP3+ Treg hücreleri ve IL-23 ekspresyonunda farklılık bulunmuyordu.Sonuçlar Ülseratif kolitli çocukların bağırsak mukozalarında FOXP3+ Treg hücreleri ve IL-23 ekspresyonu daha yüksek olduğu tespit edildi. Bu sonuçlar, IL-23 yolağını engellemeye ve Treg hücre sayılarını yükseltmeye yönelik yeni tedavi seçeneklerin, UK'in daha etkili bir şekilde tedavi edilmesine yardımcı olabileceğini göstermektedir.

🔖

Cite This Article

AKBULUT, U. E., ERSOZ, S., TUMGOR, G., AGİN, M., UNAL, F., KASİRGA, E., CAKİR, M. (2018). FOXP3+ Treg cells and interleukin-23 expression in the intestinal mucosa of children with ulcerative colitis. Mucosa, Cilt: 1 - Sayı: 1, 10–17. https://ajindex.com/articles/840069

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007; 133: 1670–89.
  2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427–34.
  3. Wang Y, Lıu XP, Zhao ZB, et al. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J Dig Dis 2011; 12: 286-94
  4. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammatory by producing interleukin 17. Nat. Immunol 2005; 6: 1133–41.
  5. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol 2005; 6: 1123–32
  6. Liu Z, Yadav PK, Xu X, Su J, et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol 2011; 89: 597-606
  7. Yang J, Xu L. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis. Med Sci Monit 2016; 22: 2785-92.
  8. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science 2006; 314: 1461–3.
  9. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64
  10. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4(+) CD25(+) regulatory T cells. J Immunol 2003; 170: 3939–43. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24: 209–26.
  11. Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13: 533–8.
  12. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18–20.
  13. Voskens CJ, Fischer A, Roessner S, et al. Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ucerative Colitis. Inflamm Bowel Dis 2017; 23: 1348-1359
  14. Abraham C, Cho JH. Inflammatory bowel disease. N. Engl. J. Med 2009; 361: 2066-78
  15. Izcue A, Hue S, Buonocore, et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-de